Real-time enrollment status for this prostate cancer patients treated by radiotherapy clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:04 PM UTC
| NCT Number | NCT07332000 |
| Recruiting Status | Recruiting |
| Condition | Prostate Cancer Patients Treated by Radiotherapy |
| Phase | PHASE2 |
| Target Enrollment | 45 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Candel Therapeutics, Inc. |
| Last Updated on CT.gov | September 15, 2026 (3 weeks ago) |
As of October 12, 2026: Clinical trial NCT07332000 is currently recruiting participants. This phase2 study for prostate cancer patients treated by radiotherapy is actively seeking new participants at 7 locations across the United States. The study is sponsored by Candel Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07332000 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07332000 was last updated 3 weeks ago (September 15, 2026). HelloStudys verifies this status automatically.